Any forward-looking statements that Bellicum makes in this press release speak only as of the date of this press release. Bellicum assumes no obligation to update our forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. Investors: Bellicum Pharmaceuticals, Inc. Alan Musso, CFO 832-384-1116 amusso@bellicum.com Media: BMC Communications Brad Miles 917-570-7340 bmiles@bmccommunications.com or BMC Communications Amy Bonanno 914-450-0349 abonanno@bmccommunications.com Source: Bellicum Pharmaceuticals